TY  - BOOK
AU  - Januzzi, James L.
TI  - Cardiac biomarkers in clinical practice
SN  - 9780763761615
AV  - RC683.5.C5 C37 2011
U1  - 616.12075 22
PY  - 2011///]
CY  - Sudbury, Mass.
PB  - Jones and Bartlett Publishers
KW  - Heart
KW  - Diseases
KW  - Diagnosis
KW  - Biochemical markers
KW  - Diagnostic use
KW  - Clinical chemistry
KW  - Biological Markers
KW  - Cardiovascular Diseases
KW  - diagnosis
KW  - prevention & control
KW  - Risk Assessment
N1  - Includes bibliographical references and index; Section One: Necrosis Markers -- Chapter 1: Biology of Standard Necrosis Markers -- Chapter 2: The Evolution and Revolution of Necrosis Markers in Modern Cardiology for the Diagnosis of Acute Myocardial Infarction -- Chapter 3: Biochemical and Analytical Issues for Cardiac Troponin -- Chapter 4: Utility of Troponin Testing for Risk Stratification and Treatment Decision Making in Acute Coronary Syndromes -- Chapter 5: Use of Cardiac Troponins in ST-Segment Elevation Myocardial Infarction -- Chapter 6: Interpretation of Cardiac Troponin Elevation in Patients with End-stage Renal Disease -- Chapter 7: Necrosis Market Testing in Heart Failure -- Chapter 8: Necrosis Markers in Conditions Other than Acute Coronary Syndromes and Heart Failure -- Chapter 9: Use of Cardiac Necrosis Biomarkers Following PCI or CABG -- Chapter 10: Emerging Biomarkers in Acute Coronoary Syndrome -- Chapter 11: Ischemia Markers -- Section Two: Inflammatory Markers -- Chapter 12: Inflammation and Inflammatory Markers in Cardiovascular Disease: From Bench to Bedside -- Chapter 13: Inflammation in The Development and Complications of Coronary Artery Disease -- Chapter 14: Role of Inflammatory Marker Testing in Acute Coronary Syndromes -- Chapter 15: Role of Inflammatory Biomarkers in heart Failure -- Section Three: Natriuretic Peptides -- Chapter 16: Biology of the Natriuretic Peptides  -- Chapter 17: Natriuretic Peptide Testing: Laboratory Considerations -- Chapter 18: Natriuretic Peptides and Structural Heart Disease -- Chapter 19: Population Testing with Natriuretic Peptides -- Chapter 20: Natriuretic Peptide Testing in Symptomatic Primary Care Patients -- Chapter 21: Natriuretic Peptide Testing for Diagnostic Evaluation of Patients with suspected Acute Hearth Failure -- Chapter 22: Natriuretic Peptide Testing for Patients with Acute and Chronic Coronary Disease -- Chapter 23: Natriuretic Peptides and Prognostication: Predicting Outcomes Across the Spectrum of Medical Conditinos -- Chapter 24: Natriuretic peptides for Guidance of Acute and Chronic Heart Failure therapy -- Chapter 25: Natriuretic Peptide Testing in Patients with Renal Disease -- Chapter 26: Emerging Biomarkers of Cardiac Failure -- Section Four: Markers of Thrombosis and Hemostasis -- Chapter 27: Rationale for Clinical Measurement of Markers in Cardiology -- Chapter 28: Markers of Platelet Function and Assessment of Platelet Activation and Aggregation -- Section Five: Lipid Markers -- Chapter 29: Contemporary Interpretation of Lipid Guidelines in Modern Medicine -- Chapter 30: Biomarkers in the Metabolic Syndrome -- Chapter 31: Emerging Lipid-Based Biomarkers -- Section Six: The "-omics": Genomic, Metabolomic, and Protecomic Markers -- Chapter 32: Genetic Biomarkers
N2  - Cardiac Biomarkers in Clinical Practice presents a case based approach to biomarkers in heart diseases including heart failure, ischemic heart disease, and outpatient. Divided into six sections, this book provides physicians and other health care providers with a clear understanding of the role of biomarkers in clinical cardiovascular medicine
ER  -